Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

COVID is less severe with Omicron than Delta, U.S. study suggests

Published 01/25/2022, 02:33 PM
Updated 01/25/2022, 03:00 PM
© Reuters. FILE PHOTO: Test tube labelled "COVID-19 Omicron variant test positive" is seen in this illustration picture taken January 15, 2022. REUTERS/Dado Ruvic

By Manojna Maddipatla and Leroy Leo

(Reuters) - The Omicron variant appears to result in less severe COVID-19 than seen during previous periods of high coronavirus transmission including the Delta wave, with shorter hospital stays, less need for intensive care and fewer deaths, according to a new U.S. study.

However, the fast-spreading Omicron variant has led to record numbers of infections and hospitalizations, straining the U.S. healthcare system.

Despite the steep spike in COVID cases, the percentage of hospitalized patients admitted to intensive care units (ICU) during the current Omicron wave was about 29% lower than during last winter's surge and some 26% lower than during the Delta wave, the study published on Tuesday in the U.S. Centers for Disease Control and Prevention's (CDC) Morbidity and Mortality Weekly Report found.

The lower COVID-19 disease severity during the Omicron period is likely related to higher vaccination coverage, booster use among those eligible for the extra shots, as well as prior infections providing some immune protection, the study said.

Deaths in the period from Dec. 19 to Jan. 15, when Omicron infections were at a peak, averaged 9 per 1,000 COVID cases, compared to 16 per 1,000 in the previous winter peak and 13 during the Delta wave, the study showed.

The findings were consistent with previous data analyses from South Africa, England and Scotland, where infections from Omicron peaked earlier than in the United States, the CDC said.

Relatively high hospitalizations among children during the Omicron period may be related to lower vaccination rates compared with adults, the agency said. Children under age 5 are not yet eligible for vaccines in the United States and the rate of vaccination among older children lags that of adults.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The study involved analysis of data from a large healthcare database and three surveillance systems to assess U.S. COVID-19 characteristics from Dec. 1, 2020 to Jan. 15, 2022.

The authors said one limitation of the study was that it was unable to exclude incidental infections in which patients admitted for other reasons test positive for COVID while in the hospital. That may inflate hospitalization-to-case ratios and affect severity indicators.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.